Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.

Daniel Engelbertsen, Jenifer Vallejo, Tâm Dan Quách, Gunilla Nordin Fredrikson, Ragnar Alm, Bo Hedblad, Harry Björkbacka, Thomas L Rothstein, Jan Nilsson, Eva Bengtsson

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Fingeravtryck

Fördjupa i forskningsämnen för ”Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.”. Tillsammans bildar de ett unikt fingeravtryck.

Biochemistry, Genetics and Molecular Biology